Zomedica (NYSEAMERICAN:ZOM) Stock Price Down 2.2% – Here’s What Happened

Shares of Zomedica Corp. (NYSEAMERICAN:ZOM) traded down 2.2% during trading on Thursday . The stock traded as low as $0.13 and last traded at $0.14. 8,794,663 shares changed hands during trading, a decline of 48% from the average session volume of 16,965,762 shares. The stock had previously closed at $0.14.

Analyst Ratings Changes

Separately, Noble Financial raised shares of Zomedica to a “strong-buy” rating in a research report on Monday, November 11th.

Zomedica Stock Performance

The stock has a market capitalization of $128.37 million, a PE ratio of -2.18 and a beta of 1.04.

Institutional Trading of Zomedica

An institutional investor recently raised its position in Zomedica stock. Geode Capital Management LLC lifted its holdings in Zomedica Corp. (NYSEAMERICAN:ZOM) by 3.3% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 9,929,716 shares of the company’s stock after purchasing an additional 321,395 shares during the period. Geode Capital Management LLC owned about 1.01% of Zomedica worth $1,363,000 at the end of the most recent reporting period. 8.95% of the stock is currently owned by institutional investors and hedge funds.

About Zomedica

Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company offers diagnostic products comprising TRUFORMA Bulk Acoustic Wave point of care diagnostic platform; TRUVIEW, a digital cystoscopy platform that offers automated slide preparation within the instrument; and VetGuardian, a zero-touch vital signs remote monitoring system.